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Abstract Long QT and Brugada syndromes are two hereditary
cardiac diseases. Brugada syndrome has so far been associated
with only one gene, SCN5A, which encodes the cardiac sodium
channel. However, in long QT syndrome (LQTS) at least six
genes, including the SCN5A, are implicated. The substitution
(D1790G) causes LQTS and the insertion (D1795) induces both
LQTS and Brugada syndromes in carrier patients. hH1/
insD1795 and hH1/D1790G mutant channels were expressed in
the tsA201 human cell line and characterized using the patch
clamp technique in whole-cell configuration. Our data revealed a
persistent inward sodium current of about 6% at 330 mV for
both D1790G and insD1795, and a reduction of 62% of channel
expression for the insD1795. Moreover, a shift of steady-state
inactivation curve in both mutants was also observed. Our
findings uphold the idea that LQT3 is related to a persistent
sodium current whereas reduction in the expression level of
cardiac sodium channels is one of the biophysical characteristics
of Brugada syndrome. ß 2000 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Long QT syndrome (LQTS) and Brugada syndrome are
two inherited cardiac disorders that cause ventricular ¢brilla-
tion and sudden death. Clinically, LQTS is characterized by
an abnormal QT interval prolongation in 12 leads electrocar-
diogram (ECG) [1^3]. However, Brugada syndrome is charac-
terized by an ST segment elevation in the right leads (V1, V2
and V3) of the ECG, a pseudo right bundle branch block and
a normal QT interval [4,5]. No structural abnormalities have
been identi¢ed in patients with either LQTS or Brugada syn-
drome. Mutations in six genes encoding di¡erent ionic chan-
nels or their accessory subunits were identi¢ed in LQTS pa-
tients. However, Brugada syndrome mutations have so far
been identi¢ed in only one gene, SCN5A, the cardiac sodium
channel gene [6^8].
Although LQTS and Brugada syndrome are known to be
distinct disorders, a recent study reported a novel mutation in
SCN5A gene that causes both syndromes [8]. In their report
[8], an in frame insertion of three nucleotides in the C-termi-
nus region of cardiac sodium channel resulting in an incorpo-
ration of aspartate at position 1795 was identi¢ed as being
responsible for both LQTS and Brugada syndrome phenotype
in one family. In their report, the authors correlated the Bru-
gada syndrome phenotype with a decrease in sodium channel
expression in Xenopus oocytes. However, the authors did not
¢nd any residual current, which represents the principal bio-
physical phenotype of mutations causing LQTS in SCN5A
known as LQT3 [9]. The reason as to why no residual current
could be recorded is not clear. Recent biophysical data re-
vealed a residual current when this mutation was expressed
in the HEK293 cell line [10]. This study reported that the
insertion mutant also a¡ects slow inactivation and therefore
contributes to Brugada syndrome features. Other studies have
reported that the acceleration of the current decay may also
cause Brugada syndrome phenotypes [11,12].
On the other hand, the physiopathology of D1790G muta-
tion found in a patient with LQTS was shown to be related to
K^L1 subunit interaction [13]. The data presented were not
clear as to how this could involve QT prolongation. However,
subsequent study from the same authors described that
D1790G mutation carriers responded to £ecainide treatment
but not to lidocaine by rectifying QTc interval [14]. The oc-
currence of a residual current due to the reduction of sodium
channel inactivation would increase the action potential dura-
tion leading to early after depolarizations, QT prolongation,
which would then degenerate into ventricular ¢brillation.
In this study, we expressed hH1/insD1795 and hH1/
D1790G channels in tsA201 cells (human embryonic kidney
cells) [15]. Our data revealed a reduction in sodium channel
expression and the presence of a persistent inward sodium
current in the case of insD1795, thus explaining both clinical
phenotypes in patients carrying this mutation. A persistent
inward sodium current could explain the LQTS features in
patients carrying the hH1/D1790G variant of the cardiac so-
dium channel.
2. Materials and methods
2.1. Mutagenesis
Mutants hH1/insD1795 and hH1/D1790G were generated using
QuickChange TM site-directed mutagenesis kit, according to the man-
ufacturer’s instructions (Stratagene, La Jolla, CA, USA).
Mutants were constructed using the following mutagenic sense and
antisense primers, respectively:
For the insertion D1795: 5P-CTT CGA TAT GTT CTA TGA
TGA GAT CTG GGA GAA ATT TG-3P and 5P-CA AAT TTC
TCC CAG ATC TCA TCA TAG AAC ATA TCG AAG-3P.
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For the mutant D1790G: 5P-GAG CCC CTG AGT GAG GAC
GGC TTC GAT ATG TTC TAT GAG-3P and 5P-CTC ATA
GAA CAT ATC GAA GCC GTC CTC ACT CAG GGG
CTC-3P.
Underlined are the inserted nucleotides.
Mutant and the wild-type hH1 in a pcDNA1 construct were puri-
¢ed using Quiagen columns (Quiagen Inc., Chatsworth, CA, USA).
2.2. Transfections of the tsA201 cell line
The mammalian cell line tsA201 is derived from human embryonic
kidney HEK293 cells by stable transfection with SV40 large T anti-
gen. Cells were grown in high glucose DMEM (Dulbecco’s modi¢ed
Eagle’s medium) supplemented with 10% fetal bovine serum, L-gluta-
mine (2 mM), penicillin G (100 U/ml) and streptomycin (10 mg/ml)
(Gibco BRL Life technologies, Burlington, Ont., Canada). Cells were
incubated in a 5% CO2 humidi¢ed atmosphere. The tsA201 cells were
transfected using the calcium phosphate method, with the following
modi¢cation: to better identify individual transfected cells, 10 Wl of
piERS/CD8/L plasmid was cotransfected with 10 Wl of either the wild-
type or the mutant hH1 sodium channels cDNA. The human sodium
channel L-subunit and CD8 were constructed in piERS vector
(piERS/CD8/L). Using this strategy, transfected cells that bind beads
will also express the L-subunit. For patch clamp experiments, 2^3 days
post-transfection cells were incubated for 2 min in a medium contain-
ing anti-CD8-a coated beads (Dynabeads M-450 CD8-a) [16]. The
unattached beads were removed by washing with extracellular solu-
tion. Beads were prepared according to the manufacturer’s instruc-
tions (Dynal A.S., Oslo, Norway). Cells expressing CD8-a on their
surface ¢xed the beads and were distinguished from non-transfected
cells by light microscopy.
2.3. Patch clamp method
Macroscopic sodium currents from transfected cells were recorded
using the whole-cell con¢guration of the patch clamp technique. Patch
electrodes were made from 8161 Corning glass and coated with Syl-
gard (Dow-Corning, Midland, MI, USA) to minimize their capaci-
tance. Low resistance electrodes (6 0.8 M6) were used, and a routine
series resistance compensation of an Axopatch 200 ampli¢er was per-
formed to values s 80% to minimize voltage-clamp errors. Voltage-
clamp command pulses were generated by microcomputer using
pCLAMP software v5.5 (Axon Instruments, Foster City, CA,
USA). Recorded sodium currents were ¢ltered at 5 kHz. Experiments
were performed 10 min after obtaining the whole-cell con¢guration to
allow the current to stabilize.
2.4. Solutions and reagents
For whole-cell recording, the patch pipet contained 35 mM NaCl,
105 mM CsF, 10 mM EGTA, and 10 mM Cs-HEPES (pH = 7.4). The
extracellular solution contained 150 mM NaCl, 2 mM KCl, 1.5 mM
CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM Na-HEPES
(pH = 7.4). A correction of the liquid junction potential of 37 mV
between patch pipet and the bath solutions was made. Experiments
were performed at ambient temperature (22^23‡C).
2.5. Statistical analysis
Data are expressed as mean þ S.E.M.
When indicated, t-test was performed using statistical software in
SigmaPlot (Jandel Scienti¢c Software, San Rafael, CA, USA). Di¡er-
ences were deemed signi¢cant at a P value 6 0.05.
3. Results
Macroscopic sodium currents from wild-type (hH1/WT),
and hH1 mutants (hH1/D1790G and hH1/insD1795) coex-
pressed with the L-subunit were recorded in whole-cell con¢g-
uration from transfected tsA201 cells. Representative inward
and outward current traces from hH1/WT, hH1/D1790G and
hH1/insD1795 transfected cells are shown in Fig. 1. Wild-type
and mutant D1790G sodium currents were characterized by a
large amplitude and fast activation and inactivation kinetics
(Fig. 1A,B). In contrast, hH1/insD1795 sodium currents were
characterized by smaller amplitudes (Fig. 1C).
Although the same amount of DNA (10 Wg) was used for
transfection with both WT and insD1795, the recorded so-
dium currents for insD1795 were signi¢cantly smaller than
for WT channels. Fig. 3A illustrates this fact, current/voltage
relationship (Fig. 3A) for both hH1/WT and hH1/insD1795
shows that hH1/insD1795 resulted in 62% (P6 0.05) reduc-
tion of sodium currents density. Sodium current densities were
corrected for membrane capacitance of each cell.
Both mutants hH1/D1790G and hH1/insD1975 showed per-
sistent inward sodium currents of about 6% at 330 mV (Fig.
1B,C). The persistent sodium current is due to late sodium
channels activity; this was demonstrated by using tetrodotox-
in (TTX), a speci¢c sodium channel blocker (Fig. 2A,B). TTX
at 10 WM reduced the persistent inward sodium current in
both hH1/D1790D and hH1/insD1795 to almost zero.
In both hH1/D1790G and hH1/insD1795, steady-state acti-
vation curve was shifted to about 10 mV and 5 mV, respec-
tively, toward the more positive voltages (Figs. 3B and 4B).
The V1=2 values are 338.10 þ 2.30 mV for hH1/insD1795+L
(n = 9) and 341.88 þ 1.82 mV for hH1/D1790G (n = 9) versus
347.24 þ 1.70 mV for the hH1/WT+L (n = 23); (P6 0.05).
Fig. 1. Whole-cell sodium current traces from hH1/WT+L-subunit
(A), hH1/D1790G+L-subunit (B) and hH1/insD1795+L-subunit (C)
expressed in tsA201 cell line. Currents were generated from a hold-
ing potential of 3140 mV from 380 to +60 mV during 30 ms in
10 mV increments. The dashed line represents the zero current.
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The slope factor for steady-state activation was signi¢cantly
a¡ected in mutated channels (P6 0.05), 313.10 þ 1.20 mV
(n = 9) for hH1/insD1795 and 310.04 þ 0.59 mV (n = 8) for
hH1/D1790G versus 36.56 þ 0.37 mV for the wild-type
(n = 21). Steady-state inactivation was also studied using a
two pulse protocol with 500 ms pre-pulse duration and the
averaged data were ¢tted with a Boltzmann function. The
steady-state inactivation curve in mutants D1790G and
insD1795 was shifted by nearly 20 mV toward more hyper-
polarized voltages (Figs. 3B and 4B). The V1=2 values for
steady-state inactivation are 3107.86 þ 1.86 mV for hH1/
D1790G+L (n = 9) and 3112.4 þ 2.73 mV for hH1/
insD1795+L (n = 20) versus 393.22 þ 1.13 mV for hH1/
WT+L (n = 21); (P6 0.05). The slope factor for steady-state
inactivation curves was not signi¢cantly a¡ected in both mu-
tant channels.
4. Discussion
All reported mutations on the SCN5A gene inducing LQTS,
known as LQT3, induce a persistent sodium current and lead
to QT interval prolongation [17^19] with the exception of the
D1790G mutant which was reported to disrupt K^L interac-
tion [13]. Our study revealed a residual sodium current in the
presence of each of these mutants, hH1/D1790G and hH1/
insD1795. It is not clear why An et al. did not record any
residual current [13]. However, there are few explanations to
these di¡erences; importantly, in contrast to their study we
used 35 mM sodium in the patch pipet. We employed cesium
£uoride instead of cesium aspartate to block potassium chan-
nels. There are other technical aspects that were not addressed
in their study, for example, it is not clear at what time after
breaking the seal the recordings were performed, because of
the shift of gating that occurs over time while recording so-
dium currents [20]. We cannot however speculate on the basis
of the precise di¡erences.
In the original study of the insertion mutation (insD1795)
expressed in Xenopus oocytes [8] no residual current was re-
corded. However, a subsequent study of insD1795 reported
the presence of residual current when this mutation was ex-
pressed in the HEK293 cells [10].
Our data support the idea that the aspartate insertion at
position 1795 could induce both the LQTS and the Brugada
syndrome. The presence of a residual current may prolong the
myocardial action potential duration and hence the QT inter-
val on the ECGs of patients carrying the insD1795 or the
D1790G. In addition, the 62% reduction of sodium channel
Fig. 2. (A) E¡ect of 10 WM of TTX on sodium current recorded
from cells expressing hH1/D1790G. (B) E¡ect of 10 WM of TTX on
sodium current recorded from cells expressing hH1/insD1795. So-
dium currents from both hH1/insD1795+L and hH1/D1790G were
recorded from a holding potential of 3140 mV to a voltage test of
330 mV, before and at steady-state TTX e¡ect. The dashed line
represents the zero current.
Fig. 3. Current^voltage relationship for normalized amplitudes of
sodium currents to the cell capacitance of both hH1/WT+L (n = 22)
with dotted line (open circles) and hH1/insD1795+L (n = 21) with
straight line (black circles) (A). Steady-state voltage dependence of
activation and inactivation curves in normal and mutated sodium
channels ¢tted to a Boltzmann distribution (B).
FEBS 24451 27-12-00
G. Baroudi, M. Chahine/FEBS Letters 487 (2000) 224^228226
expression could well be the main cause of Brugada syndrome
phenotype in patients carrying the insD1795 mutation. It was
also reported that this insertion mutant could also interfere
with recovery from intermediate inactivation, this would con-
tribute to Brugada phenotype [10]. This reduction in sodium
currents is unlikely to be related to the slowing of recovery
from the intermediate state of inactivation which has a time
constant of 92.7 ms [10]. In our study we used a 0.2 Hz pulse
frequency (5 s interpulse duration) for recording sodium cur-
rents. Furthermore, longer interpulse durations (10, 20 and 30
s) were also studied and only slight e¡ects were observed (data
not shown). Moreover, recovery from fast inactivation at
holding potentials 3130 mV and 3140 mV of hH1/
D1790G, hH1/insD1795 and hH1/WT did not di¡er (data
not shown). Sodium currents are further diminished due to
the 20 mV shift of the steady-state inactivation curve and this
could contribute to the Brugada phenotype.
Most of the mutations causing the Brugada syndrome result
in either a reduction of sodium channel expression [6,7] or a
slowing of recovery from fast inactivation [7,15]. Recently,
Dumaine et al. reported that the T1620M mutation in hH1
sodium channels causing the Brugada syndrome accelerates
current decay at 37‡C [11]. In their report, slowing of recovery
from fast inactivation compared to the wild-type was also
observed but not considered to be responsible for the Brugada
syndrome phenotype. More recently the T1620M mutation
was also found to enhance sodium channels intermediate in-
activation [21].
It is now well accepted that reduction in sodium currents
(smaller depolarizing inward current) favors potassium out-
ward currents (abundant in the epicardium [22]) leading to a
heterogeneity of repolarization between endocardial and epi-
cardial layer of the ventricle, seen as an ST segment elevation
in the right leads of the ECG. We suspect that the reduction
of sodium channel expression will also result in the shortening
of action potential duration in both endocardium and epicar-
dium [23]. However, in the epicardium the activation of Ito
(transient outward current) would further reduce the duration
of the action potential and thus inducing ST segment eleva-
tion and the Brugada syndrome phenotype.
The insertion of an extra negative charge residue D1795 in
the C-terminal region, which is already highly acidic, could
disturb an electrostatic interaction with the rest of the channel
or even induce a disruptive change in the conformation of the
C-terminal region [24].
In conclusion, our data suggest that a single amino acid
mutation could have a double consequence on the biophysical
properties of the channel resulting in distinct clinical pheno-
types. Hence, our data support the concept that LQT3 is
related to a gain of cardiac sodium channel function, whereas
the Brugada syndrome is associated with a loss of function of
these channels.
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